Koers OWC Pharmaceutical Research Corp.
Aandelen
OWCP
US67109N1081
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,000001 USD | 0,00% |
|
0,00% | 0,00% |
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 15,37 mln. 14,35 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -4 mln. -3,73 mln. | Nettowinst (verlies) 2018 | -10 mln. -9,34 mln. | EV/omzet 2017 | - |
Nettoliquiditeiten 2017 | 971K 906K | Nettoliquiditeiten 2018 | 3,46 mln. 3,23 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 |
-14,5
x | K/w-verhouding 2018 |
-1,21
x | Werknemers | 9 |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ziv Turner
CEO | Chief Executive Officer | 52 | 21-06-20 |
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 16-06-14 |
Yehuda Baruch
CTO | Chief Tech/Sci/R&D Officer | 67 | 02-11-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 25-06-20 |
Ziv Turner
CEO | Chief Executive Officer | 52 | 21-06-20 |
Hannah Fayer
BRD | Director/Board Member | 69 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
21-06-24 | 0,000001 | 0,00% | 70 440 |
20-06-24 | 0,000001 | 0,00% | 500 |
uitgestelde koers OTC Markets, 21 juni 2024 om 17:50 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
0,00% | 497 | |
-34,15% | 14,67 mld. | |
-55,36% | 2,2 mld. | |
+17,78% | 1,83 mld. | |
-14,62% | 1,42 mld. | |
+16,53% | 1,18 mld. | |
-24,88% | 864 mln. | |
+1,40% | 784 mln. | |
-37,13% | 723 mln. | |
+19,58% | 575 mln. |